Latest News - Danaher
Top Corporates Hub
Danaher
5 Must-Read Analyst Questions From Danaher’s Q3 Earnings Call
28.10.2025 05:34
Danaher’s third quarter was marked by solid execution across its core businesses, with management citing bioprocessing momentum and a stronger-than-anticipated performance in respiratory diagnostics as key drivers. CEO Rainer Blair highlighted that demand for monoclonal antibody production remained robust, propelling bioprocessing growth, while Cepheid’s respiratory testing revenues benefited from customers ordering earlier than usual. Management also pointed to disciplined cost management and o
Unlocking Danaher (DHR) International Revenues: Trends, Surprises, and Prospects
27.10.2025 13:15
Explore Danaher's (DHR) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Why Analysts See the Danaher Story Shifting Amid Mixed Signals and Evolving Growth Forecasts
22.10.2025 20:12
Danaher's stock has seen its Fair Value Estimate increase to $247.30 from $244.50, even as growth projections become more mixed across the industry. Recent analyst commentary shows a split between optimism about stabilization within key segments and caution about the pace of recovery ahead. Stay tuned to learn how you can keep up with the evolving Danaher story as market views continue to shift. What Wall Street Has Been Saying ? Bullish Takeaways BofA continues to rate Danaher as a Buy,...
Danaher (DHR) Jumps on Improved Q3 Earnings
22.10.2025 18:48
We recently published 10 Stocks Leaving Wall Street in the Dust. Danaher Corp. (NYSE:DHR) is one of the best performers on Tuesday. Danaher bounced back by 5.94 percent on Tuesday to close at $220.77 apiece after achieving an improved earnings performance in the third quarter of the year. In an updated report, Danaher Corp. (NYSE:DHR) […]
Danaher: Regaining Growth Momentum
22.10.2025 10:49
Discover Danaher's strong Q3 results, strategic reinvestments, and biotech growth. See why DHR is poised for future earnings expansion.
Danaher Still A Hold: Good Q3 Results Alone Don't Make A Great Investment
22.10.2025 08:10
Danaher posts solid Q3/25 growth but faces valuation concerns and global risks.
Integrated DNA Technologies and Profluent Collaborate to Unlock New Frontier of AI-driven Protein Design
21.10.2025 12:56
REDWOOD CITY, Calif. & EMERYVILLE, Calif., October 21, 2025--Profluent Bio's AI-driven protein design and IDT’s enzymology and genomics expertise unite to explore new paths for developing novel enzyme variants.
Danaher (DHR) Q3 Earnings and Revenues Beat Estimates
21.10.2025 11:15
Danaher (DHR) delivered earnings and revenue surprises of +10.53% and +0.94%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Danaher Corporation (DHR) Q3 2025 Earnings Call Transcript
21.10.2025 11:14
Danaher Corporation (NYSE:DHR) Q3 2025 Earnings Call October 21, 2025 8:00 AM EDTCompany ParticipantsJohn Bedford - Vice President of Investor...
Danaher beats Q3 forecasts, issues soft full-year profit outlook; shares slip
21.10.2025 10:44
Investing.com -- Danaher reported third-quarter results that topped analyst expectations, while its full-year profit outlook narrowly missed consensus estimates at the midpoint.
Danaher Sales and Profit Rise on Bioprocessing Momentum
21.10.2025 10:23
Danaher recorded higher third-quarter sales and profit on the back of momentum in its bioprocessing business and better-than-expected sales in its respiratory market.
Danaher’s (NYSE:DHR) Q3 Sales Beat Estimates
21.10.2025 10:17
Diversified science and technology company Danaher (NYSE:DHR) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 4.4% year on year to $6.05 billion. On the other hand, next quarter’s revenue guidance of $6.70 billion was less impressive, coming in 4.7% below analysts’ estimates. Its non-GAAP profit of $1.89 per share was 9.8% above analysts’ consensus estimates.
Danaher: Q3 Earnings Snapshot
21.10.2025 10:09
On a per-share basis, the Washington-based company said it had profit of $1.27. Earnings, adjusted for one-time gains and costs, came to $1.89 per share. The results surpassed Wall Street expectations.
Danaher Reports Third Quarter 2025 Results
21.10.2025 10:00
Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended September 26, 2025.
Danaher Corporation 2025 Q3 - Results - Earnings Call Presentation
21.10.2025 08:30
2025-10-21. The following slide deck was published by Danaher Corporation in conjunction with their 2025 Q3 earnings call.
Wall Street drifts near its record heights
21.10.2025 04:26
The U.S. stock market is drifting near its record heights on Tuesday as the floodgates open for companies reporting how much profit they made during the summer. The S&P 500 slipped 0.1% in morning trading and is sitting 0.4% below its all-time high set earlier this month. General Motors rallied 14.3% after reporting stronger quarterly results than analysts expected, while also raising its forecasts for some full-year financial targets.
Danaher Earnings: What To Look For From DHR
20.10.2025 03:04
Diversified science and technology company Danaher (NYSE:DHR) will be announcing earnings results this Tuesday morning. Here’s what to expect.